Cardiovascular Systems (CSII) Tops Q4 EPS by 5c; Offers Q1 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Needham & Company Raises Price Target on Cardiovascular Systems (CSII) to $27 Following 4Q Beat
August 4, 2016 8:14 AM EDTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $27.00 (from $23.00), following the company's 4Q earnings report. Revenue was $48.5M vs. consensus of $46.0M and GAAP EPS was ($0.15) vs. consensus of ($0.20).
Analyst Mike Matson... More
BofA/Merrill Lynch Upgrades Cardiovascular Systems (CSII) to Neutral
August 4, 2016 6:51 AM EDTBofA/Merrill Lynch upgraded Cardiovascular Systems (NASDAQ: CSII) from Underperform to Neutral.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $19.74 yesterday.
... More